In particular, obesity is a risk factor for health issues such as diabetes, heart disease, stroke and sleep apnea, according to Dr. Tom Elliott, medical director of B.C.
Henry, a member of the Ochapowace Cree First Nation in Saskatchewan whose traditional name is kihci têpakohp iskotêw iskwêw, remembers growing up without much food.
Beyond the petition, Zentner said she pitched the idea of the province covering the drugs directly to Premier David Eby in a 2023 meeting, but more remains to be done.
In a statement to CBC News, the province's Ministry of Health confirmed that Ozempic is only covered for Type 2 diabetes treatment and not weight loss.
It added that Health Canada has approved semaglutide under the brand name Wegovy for chronic weight management among adult patients.
The ministry did note a 2023 study in the New England Journal of Medicine which demonstrates that the drug reduces the risk of major adverse cardiovascular events.
The original article contains 761 words, the summary contains 155 words. Saved 80%. I'm a bot and I'm open source!